Uncovering Investor Claims: Pomerantz Law Firm Investigates R1 RCM Inc. (RCM) on Behalf of Shareholders

Investigation into R1 RCM Inc. by Pomerantz Law Firm New York, Oct. 19, 2023 (GLOBE NEWSWIRE) Pomerantz LLP is currently investigating claims on behalf of investors of R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM). Investors who have been affected are urged to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The…

Read More

Breaking News: Shareholder Alert – Levi & Korsinsky LLP Launches Investigation into Potential Securities Fraud by Officers of Alnylam Pharmaceuticals Inc. (ALNY)

Breaking News: Shareholder Alert – Levi & Korsinsky LLP Launches Investigation into Potential Securities Fraud by Officers of Alnylam Pharmaceuticals Inc. (ALNY) NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, Inc. (“Alnylam”) (NASDAQ: ALNY) concerning possible violations of federal securities laws….

Read More

Attention Shareholders: Important Update on Nikola Corporation – Pomerantz Law Firm Reminds Investors of Class Action Lawsuit and Upcoming Deadline (NKLA)

A Class Action Lawsuit Against Nikola Corporation New York, Oct. 19, 2023 (GLOBE NEWSWIRE) Pomerantz LLP announces that a class action lawsuit has been filed against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA) and certain officers. The class action, filed in the United States District Court for the District of Arizona, and docketed under…

Read More

Clever, Personable, and Unconventional: Petra Funds Group Secures Strategic Investment from Charlesbank Capital Partners

Clever, personable, and wonderfully unconventional, yet reader-friendly Petra Funds Group Announces Strategic Investment from Charlesbank Capital Partners The partnership will enable fund administrator Petra to optimize and scale its white-glove service and client offerings NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Petra Funds Group (“Petra”), a leading fund administrator serving private investment firms, announced…

Read More

Breaking News: Sabin Vaccine Institute Launches Phase 2 Clinical Trial for Marburg Vaccine in Uganda – A Major Step Towards Global Health!

Clinical Trial Preparation Staff at Makerere University Walter Reed Project preparing for Sabin’s Phase 2 Marburg vaccine clinical trial Exciting News for Vaccine Development WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus. Healthy volunteers received the…

Read More

Revolutionizing Device Health Monitoring: AITX’s RAD Subsidiary Unveils Rupert, the Cutting-Edge Cloud-Based Tool

AITX’s Subsidiary RAD Releases RUPERT, an Advanced Cloud-Based Device Health System Introduction Detroit, Michigan, Oct. 19, 2023 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions for enterprise clients along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced the production…

Read More